PortfoliosLab logoPortfoliosLab logo
MDEV vs. PSIL
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

MDEV vs. PSIL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in First Trust Indxx Medical Devices ETF (MDEV) and AdvisorShares Psychedelics ETF (PSIL). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, MDEV achieves a -11.48% return, which is significantly lower than PSIL's 20.15% return.


MDEV

1D
0.04%
1M
1.54%
YTD
-11.48%
6M
-12.29%
1Y
-7.05%
3Y*
-2.86%
5Y*
10Y*

PSIL

1D
-2.57%
1M
1.88%
YTD
20.15%
6M
23.74%
1Y
65.52%
3Y*
9.55%
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

MDEV vs. PSIL - Yearly Performance Comparison


2026 (YTD)20252024202320222021
MDEV
First Trust Indxx Medical Devices ETF
-11.48%2.00%1.79%7.55%-28.59%-5.14%
PSIL
AdvisorShares Psychedelics ETF
20.15%74.55%-19.50%-25.12%-67.24%-41.98%

Correlation

The correlation between MDEV and PSIL is 0.28, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.28

Correlation (3Y)
Calculated over the trailing 3-year period

0.32

Correlation (All Time)
Calculated using the full available price history since Sep 17, 2021

0.37

MDEV vs. PSIL - Sectors Allocation Comparison


Sectors
MDEV
PSIL

Healthcare

100.0%
100.0%

Basic Materials

-

-

Communication Services

-

-

Consumer Cyclical

-

-

Consumer Defensive

-

-

Energy

-

-

Financial Services

-

-

Industrials

-

-

Real Estate

-

-

Technology

-

-

Utilities

-

-

Healthcare

MDEV
100.0%
PSIL
100.0%

Basic Materials

MDEV

-

PSIL

-

Communication Services

MDEV

-

PSIL

-

Consumer Cyclical

MDEV

-

PSIL

-

Consumer Defensive

MDEV

-

PSIL

-

Energy

MDEV

-

PSIL

-

Financial Services

MDEV

-

PSIL

-

Industrials

MDEV

-

PSIL

-

Real Estate

MDEV

-

PSIL

-

Technology

MDEV

-

PSIL

-

Utilities

MDEV

-

PSIL

-

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

MDEV vs. PSIL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

MDEV
MDEV Risk / Return Rank: 55
Overall Rank
MDEV Sharpe Ratio Rank: 55
Sharpe Ratio Rank
MDEV Sortino Ratio Rank: 55
Sortino Ratio Rank
MDEV Omega Ratio Rank: 55
Omega Ratio Rank
MDEV Calmar Ratio Rank: 55
Calmar Ratio Rank
MDEV Martin Ratio Rank: 44
Martin Ratio Rank

PSIL
PSIL Risk / Return Rank: 4848
Overall Rank
PSIL Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
PSIL Sortino Ratio Rank: 4343
Sortino Ratio Rank
PSIL Omega Ratio Rank: 4343
Omega Ratio Rank
PSIL Calmar Ratio Rank: 6666
Calmar Ratio Rank
PSIL Martin Ratio Rank: 4343
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MDEV vs. PSIL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for First Trust Indxx Medical Devices ETF (MDEV) and AdvisorShares Psychedelics ETF (PSIL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


MDEVPSILDifference
Sharpe ratioReturn per unit of total volatility

-2.02

Sortino ratioReturn per unit of downside risk

-2.66

Omega ratioGain probability vs. loss probability

0.94

1.27

-0.33

Calmar ratioReturn relative to maximum drawdown

-0.39

3.23

-3.62

Martin ratioReturn relative to average drawdown

-0.98

6.82

-7.80

MDEV vs. PSIL - Sharpe Ratio Comparison

The current MDEV Sharpe Ratio is -0.44, which is lower than the PSIL Sharpe Ratio of 1.58. The chart below compares the historical Sharpe Ratios of MDEV and PSIL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


MDEVPSILDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-0.44

1.58

-2.02

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.32

-0.42

+0.10

Drawdowns

MDEV vs. PSIL - Drawdown Comparison

The maximum MDEV drawdown since its inception was -42.34%, smaller than the maximum PSIL drawdown of -92.72%. Use the drawdown chart below to compare losses from any high point for MDEV and PSIL.


Loading charts...

Drawdown Indicators


MDEVPSILDifference

Max Drawdown

Largest peak-to-trough decline

-42.34%

-92.72%

+50.38%

Max Drawdown (1Y)

Largest decline over 1 year

-18.13%

-20.38%

+2.25%

Max Drawdown (3Y)

Largest decline over 3 years

-22.50%

-64.62%

+42.12%

Current Drawdown

Current decline from peak

-33.76%

-76.63%

+42.87%

Average Drawdown

Average peak-to-trough decline

-25.65%

-76.76%

+51.11%

Ulcer Index

Depth and duration of drawdowns from previous peaks

7.22%

9.63%

-2.41%

Volatility

MDEV vs. PSIL - Volatility Comparison

The current volatility for First Trust Indxx Medical Devices ETF (MDEV) is 4.60%, while AdvisorShares Psychedelics ETF (PSIL) has a volatility of 9.76%. This indicates that MDEV experiences smaller price fluctuations and is considered to be less risky than PSIL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


MDEVPSILDifference

Volatility (1M)

Calculated over the trailing 1-month period

4.60%

9.76%

-5.16%

Volatility (6M)

Calculated over the trailing 6-month period

11.42%

27.89%

-16.47%

Volatility (1Y)

Calculated over the trailing 1-year period

16.00%

41.80%

-25.80%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

18.98%

63.15%

-44.17%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

18.98%

63.15%

-44.17%

MDEV vs. PSIL - Expense Ratio Comparison

MDEV has a 0.70% expense ratio, which is lower than PSIL's 1.00% expense ratio.


Dividends

MDEV vs. PSIL - Dividend Comparison

MDEV has not paid dividends to shareholders, while PSIL's dividend yield for the trailing twelve months is around 8.32%.


PositionTTM2025202420232022
MDEV
First Trust Indxx Medical Devices ETF
0.00%0.00%0.00%0.00%0.00%
PSIL
AdvisorShares Psychedelics ETF
8.32%10.95%1.49%0.24%2.91%

Frequently Asked Questions


MDEV and PSIL have a correlation of 0.28, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

PSIL has higher volatility (9.76%) compared to MDEV (4.60%). In terms of maximum drawdown, MDEV dropped -42.34% vs PSIL's -92.72%.

On 3-year performance, PSIL leads with 9.55% vs -2.86% for MDEV. On fees, MDEV is cheaper at 0.70% per year. On volatility, MDEV has been the lower-risk option at 4.60%. The better choice depends on whether you care most about return, fees, risk, or income.

Over the 3-year period, PSIL has performed better with a 9.55% return vs -2.86%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

MDEV is cheaper with a 0.70% expense ratio, compared with 1.00% for PSIL.

PSIL has the higher dividend yield at 8.32%, compared with 0.00% for MDEV.

They also come from different issuers: First Trust and AdvisorShares. Their fees differ too: 0.70% for MDEV and 1.00% for PSIL.

PSIL currently has the higher Sharpe Ratio (1.58 vs -0.44), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for MDEV and PSIL

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer